We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




LIMS Market Expanding in Eastern Europe

By HospiMedica staff writers
Posted on 10 Mar 2006
Print article
Companies in Eastern Europe are increasingly implementing laboratory-information-management systems (LIMS) to make the most of available laboratory resources and enhance productivity as well as efficiency, according to a new report from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm. As a result, market revenues are expected to increase at a compound annual growth of 8.4%.

The LIMS market offers many opportunities for vendors who can achieve strong product differentiation for new laboratory experimental requirements. Thus, vendors are providing interactive, customer-friendly features that enhance sample traceability, instrument interfacing, and final report generation in a formatted manner.

Foreign investment in the pharmaceutical industry has been increasing in many countries of Eastern Europe such as Poland, the Czech Republic, and Russia. Since many of these companies have business operations at multiple sites, they will have to comply with certain regulatory measures such as the International Organization for Standardization (ISO) 17025 and Good Manufacturing Practice (GMP). A research analyst with Frost & Sullivan has noted that LIMS vendors will have to provide quality control software packages with more robustness to meet the changing demands of the pharmaceutical industry.

Pharmaceutical companies that consider purchasing LIMS will access their needs very carefully before making such a large investment. With legacy systems already in place, many companies might not feel a need to replace these systems with modern second-generation configurable solutions. Companies are concerned about migration of data from legacy systems to second-generation LIMS, and expect to be able to transfer data from old systems to new systems.

With Eastern Europe providing a cost-friendly business environment, LIMS vendors need to streamline operations and offer superior local customer support. They will also need to provide multilingual support systems that suit the demands of the respective countries in this region.




Related Links:
Frost & Sullivan
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.